biotech.today

Details

  • ●Modalities: small molecules, antibodies, protein complexes
  • ●Therapeutic areas: Undisclosed
  • ●Key targets:
  • ●Indications: Undisclosed
  • ●Funding: $30M

Partners & investors

  • OpenAI· Investor
  • OpenAI Startup Fund· Investor

Key considerations

  • ●AI tools in use: Chai-1, Chai-2, Chai Platform
  • ●Chai-1 technical report December 2024
  • ●Chai-2 antibody design release 2025
  • ●$30M Series A led by OpenAI Startup Fund (Feb 2024)
Get live updates on Chai Discovery’s hiring, filings, and partnerships. Follow in BT Pro →
Source: Company website, SEC / Companies House filings, press releases, Crunchbase · biotech.today analysis (Apr 2026)

Key people

Joshua Meier

Co-Founder & CEO

protein-language-modelsco-foldingex-Meta-FAIR
Visit website →LinkedIn →